You are here
Op-T-Mune, Inc
UEI: K2XFYLHNXPY3
# of Employees: 5
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes
Amount: $1,764,501.00Type 1 Diabetes (T1D) affects an ever growing population. While this disease typically has been associated with juveniles, the disease in adult populations is rapidly increasing. The defining clinical ...
STTRPhase II2019Department of Health and Human Services National Institutes of Health -
Development of a Clinical Screening Platform for Type 1 Diabetes
Amount: $1,155,286.00AbstractA major shortfall in clinical care for diabetes is a rapid and accurate screen for progression to diseaseCurrent criteria involve HLA haplotypeand the presence of auto antibodiesAAGenome wide ...
STTRPhase II2018Department of Health and Human Services National Institutes of Health -
Developing a small peptide to control autoimmune inflammation in type diabetes
Amount: $297,387.00Abstract Type Diabetes T D affects an ever growing population While this disease typically has been associated with juveniles the disease in adult populations is rapidly increasing The definin ...
STTRPhase I2017Department of Health and Human Services National Institutes of Health -
Screening for the autoimmune component of multiple sclerosis
Amount: $299,002.00Multiple Sclerosis is an inflammatory neurodegenerative disease with autoimmune components that exacerbate and potentially initiate the disease Diagnosis is invasive time consuming relatively expen ...
STTRPhase I2017Department of Health and Human Services National Institutes of Health -
Development of a Clinical Screening Platform for Type Diabetes
Amount: $421,182.00Abstract A major shortfall in clinical care for diabetes is a rapid and accurate screen for progression to disease Current criteria involve HLA haplotype and the presence of auto antibodies AA G ...
STTRPhase I2017Department of Health and Human Services National Institutes of Health -
Developing a new treatment for MS: Controlling CD40 in EAE
Amount: $211,808.00DESCRIPTION (provided by applicant): The National Multiple Sclerosis (MS) Society reports that 1.2 million people worldwide and more than 400,000 people in the U.S. have clinically diagnosed MS. Curre ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
Screening for Type 1 Diabetes: A blood test based on the CD40 biomarker
Amount: $300,000.00DESCRIPTION (provided by applicant): The goal of this application is to develop a test kit to quickly and accurately diagnose type 1diabetes; differentiate it from type 2 diabetes and screen for pr ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health
